BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8891723)

  • 81. Cyclins, Cyclin-Dependent Kinases, and Cyclin-Dependent Kinase Inhibitors in the Mouse Nervous System.
    Grison A; Atanasoski S
    Mol Neurobiol; 2020 Jul; 57(7):3206-3218. PubMed ID: 32506380
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy.
    Chou J; Quigley DA; Robinson TM; Feng FY; Ashworth A
    Cancer Discov; 2020 Mar; 10(3):351-370. PubMed ID: 32071145
    [TBL] [Abstract][Full Text] [Related]  

  • 83. p27Kip1 metabolism: a fascinating labyrinth.
    Borriello A; Cucciolla V; Oliva A; Zappia V; Della Ragione F
    Cell Cycle; 2007 May; 6(9):1053-61. PubMed ID: 17426451
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications.
    Sofi S; Mehraj U; Qayoom H; Aisha S; Asdaq SMB; Almilaibary A; Mir MA
    Med Oncol; 2022 Apr; 39(6):106. PubMed ID: 35486263
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Interconnection between Metabolism and Cell Cycle in Cancer.
    Icard P; Fournel L; Wu Z; Alifano M; Lincet H
    Trends Biochem Sci; 2019 Jun; 44(6):490-501. PubMed ID: 30655165
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Heat shock effects on cell cycle progression.
    Kühl NM; Rensing L
    Cell Mol Life Sci; 2000 Mar; 57(3):450-63. PubMed ID: 10823246
    [TBL] [Abstract][Full Text] [Related]  

  • 87. An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs.
    Bencivenga D; Stampone E; Vastante A; Barahmeh M; Della Ragione F; Borriello A
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456025
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Targeting cell cycle regulators in hematologic malignancies.
    Aleem E; Arceci RJ
    Front Cell Dev Biol; 2015; 3():16. PubMed ID: 25914884
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions.
    Juric V; Murphy B
    Cancer Drug Resist; 2020; 3(1):48-62. PubMed ID: 35582046
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The SIAMESE family of cell-cycle inhibitors in the response of plants to environmental stresses.
    Braat J; Havaux M
    Front Plant Sci; 2024; 15():1362460. PubMed ID: 38434440
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Immunomodulatory Roles of Cell Cycle Regulators.
    Laphanuwat P; Jirawatnotai S
    Front Cell Dev Biol; 2019; 7():23. PubMed ID: 30863749
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies-Current Understanding, (Pre-)Clinical Application and Promising Approaches.
    Richter A; Schoenwaelder N; Sender S; Junghanss C; Maletzki C
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065376
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition.
    Gérard C; Goldbeter A
    Interface Focus; 2014 Jun; 4(3):20130075. PubMed ID: 24904738
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Investigating the Mechanism of Inhibition of Cyclin-Dependent Kinase 6 Inhibitory Potential by Selonsertib: Newer Insights Into Drug Repurposing.
    Baig MH; Yousuf M; Khan MI; Khan I; Ahmad I; Alshahrani MY; Hassan MI; Dong JJ
    Front Oncol; 2022; 12():865454. PubMed ID: 35720007
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Polymorphism of p16INK4a gene and rare mutation of p15INK4b gene exon2 in primary hepatocarcinoma.
    Qin Y; Li B; Tan YS; Sun ZL; Zuo FQ; Sun ZF
    World J Gastroenterol; 2000 Jun; 6(3):411-414. PubMed ID: 11819612
    [No Abstract]   [Full Text] [Related]  

  • 96. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
    Hao Y; Baker D; Ten Dijke P
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195692
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.
    Deng M; Wang J; Chen Y; Zhang L; Xie G; Liu Q; Zhang T; Yuan P; Liu D
    Mol Med Rep; 2016 Aug; 14(2):1523-30. PubMed ID: 27314680
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A distant, cis-acting enhancer drives induction of Arf by Tgfβ in the developing eye.
    Zheng Y; Devitt C; Liu J; Mei J; Skapek SX
    Dev Biol; 2013 Aug; 380(1):49-57. PubMed ID: 23665474
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours.
    Di Vizio D; Demichelis F; Simonetti S; Pettinato G; Terracciano L; Tornillo L; Freeman MR; Insabato L
    BMC Cancer; 2008 May; 8():134. PubMed ID: 18474118
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts.
    Rosania GR; Merlie J; Gray N; Chang YT; Schultz PG; Heald R
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4797-802. PubMed ID: 10220373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.